Ian M. Franklin

4.8k total citations · 2 hit papers
77 papers, 3.3k citations indexed

About

Ian M. Franklin is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Ian M. Franklin has authored 77 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 20 papers in Genetics and 13 papers in Oncology. Recurrent topics in Ian M. Franklin's work include Hematopoietic Stem Cell Transplantation (20 papers), Multiple Myeloma Research and Treatments (12 papers) and Acute Myeloid Leukemia Research (12 papers). Ian M. Franklin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Multiple Myeloma Research and Treatments (12 papers) and Acute Myeloid Leukemia Research (12 papers). Ian M. Franklin collaborates with scholars based in United Kingdom, United States and Australia. Ian M. Franklin's co-authors include Anthony H. Goldstone, Mark R. Litzow, Martin S. Tallman, Hillard M. Lazarus, Jacob M. Rowe, Georgina Buck, Susan Richards, Adele K. Fielding, David I. Marks and Andrew McMillan and has published in prestigious journals such as The Lancet, Blood and The Journal of Immunology.

In The Last Decade

Ian M. Franklin

73 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

2006 591 citations Adele K. Fielding, Susan Richards et al. Blood profile →
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

2007 537 citations Anthony H. Goldstone, Susan Richards et al. Blood profile →

Peers

Countries citing papers authored by Ian M. Franklin

Since Specialization

Citations

This map shows the geographic impact of Ian M. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Franklin more than expected).

Fields of papers citing papers by Ian M. Franklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian M. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Franklin. The network helps show where Ian M. Franklin may publish in the future.

Co-authorship network of co-authors of Ian M. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Franklin. A scholar is included among the top collaborators of Ian M. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Franklin. Ian M. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Syphilis nucleic acid testing: usefulness in syphilis confirmation? 2009 ·Transfusion ·B. C. Dow, Ian M. Franklin, (unknown), Rory Gunson	4
2	Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy 2008 ·Leukemia & lymphoma ·Simon J. Harrison, Ian M. Franklin, John Campbell	11
3	Bilateral nephrectomy for uncontrollable nephrotic syndrome in primary amyloidosis, with subsequent improvement in hepatic function 2008 ·Clinical & Laboratory Haematology ·Nicola Bienz, Ian M. Franklin, Dwomoa Adu, (unknown), Philip D. McMaster, S.G. Hübscher	0
4	In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) breakdown → 2007 ·Blood ·Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus, Martin S. Tallman, Georgina Buck, Adele K. Fielding, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Letizia Foroni, Elisabeth Paietta, Mark R. Litzow, David I. Marks, Jill Durrant, Andrew McMillan, Ian M. Franklin, Selina M. Luger, Niculae Ciobanu, Jacob M. Rowe	537
5	The EU optimal blood use project 2007 ·Transfusion Clinique et Biologique ·(unknown), D. B. L. McClelland, Ian M. Franklin	5
6	Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial 2005 ·The Lancet Oncology ·James W. Denham, Allison Steigler, David S. Lamb, David Joseph, Hedy Mameghan, Sandra Turner, John Matthews, Ian M. Franklin, Chris Atkinson, J. B. North, Michael Poulsen, David Christie, Nigel Spry, Keen‐Hun Tai, Chris Wynne, Gillian Duchesne, (unknown), Catherine D’Este	287
7	Adult patients with acute lymphoblastic leukaemia (ALL) who relapse have a dismal outlook: Results from MRC UKALL XII/ECOG 2993 trial. 2003 ·Blood ·Reena Chopra, A H Goldstone, Georgina Buck, S Richards, Ian M. Franklin, H M Lazarus, (unknown), Martin S. Tallman, H. G. Prentice, Jill Durrant, Jacob M. Rowe	1
8	Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer 2003 ·Radiotherapy and Oncology ·David S. Lamb, James W. Denham, Hedy Mameghan, David Joseph, Sandra Turner, John Matthews, Ian M. Franklin, Chris Atkinson, J. B. North, Michael Poulsen, (unknown), (unknown), (unknown), David Christie, Nigel Spry, Keen Hun Tai, Chris Wynne, Gillian Duchesne	30
9	Suppression of IL-2-Induced T Cell Proliferation and Phosphorylation of STAT3 and STAT5 by Tumor-Derived TGFβ Is Reversed by IL-15 2001 ·The Journal of Immunology ·John Campbell, Gordon Cook, Susan Robertson, Alasdair R. Fraser, (unknown), J. Alastair Gracie, Ian M. Franklin	66
10	Expression of adhesion molecules in malignant plasma cells in multiple myeloma: comparison with normal plasma cells and functional significance 1997 ·Blood Reviews ·Miep Helfrich, (unknown), Ian M. Franklin, Richard Soutar	15
11	The Role of Adhesion Molecules in Multiple Myeloma 1997 ·Acta Haematologica ·(unknown), (unknown), Ian M. Franklin	41
12	TEL‐AML1 fusion in acute lymphoblastic leukaemia of adults 1996 ·British Journal of Haematology ·Ricardo C.T. Aguiar, Jastinder Sohal, Frits van Rhee, Melina Carapeti, Ian M. Franklin, Anthony H. Goldstone, John M. Goldman, Nicholas C.P. Cross	63
13	Very late antigen (VLA) expression by normal and neoplastic human plasma cells; including an assessment of antibodies submitted to the Vth International Workshop on Leucocyte Differentiation Antigens using human myeloma cell lines 1996 ·Leukemia Research ·Marion Drew, Helen F. Barker, Jennifer Ball, C. Pearson, (unknown), Ian M. Franklin	13
14	Multiple myeloma: The biology of malignant plasma cells 1993 ·Blood Reviews ·Helen F. Barker, Jennifer Ball, Marion Drew, Ian M. Franklin	8
15	Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells 1992 ·British Journal of Haematology ·Helen F. Barker, Malcolm Hamilton, Jennifer Ball, Marion Drew, Ian M. Franklin	62
16	Rheological changes in the prodromal and established phases of sickle cell vaso‐occlusive crisis 1992 ·British Journal of Haematology ·N O Akinola, (unknown), Ian M. Franklin, Gerard B. Nash, J. Stuart	38
17	Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect 1988 ·British Journal of Haematology ·Jane F. Apperley, Francesca Romana Mauro, John M. Goldman, W. Gregory, C. Arthur, Jill Hows, William Arcese, Giuseppe Francesco Sferrazza Papa, Franco Mandelli, (unknown), P Gravett, Ian M. Franklin, Giuseppe Bandini, Paolo Ricci, S Tura, A Iacone, G Torlontano, W. Heit, Richard E. Champlin, Robert Peter Gale	152
18	Unexplained lymphadenopathy in sickle cell disease 1988 ·European Journal Of Haematology ·A. J. Keidan, Morgan Hamon, Ian M. Franklin, (unknown)	0
19	Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides. 1986 ·BMJ ·Robert W. Wilkinson, (unknown), David A. Heath, Ian M. Franklin, B. J. Boughton	9
20	Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents. 1986 ·BMJ ·(unknown), Jonathan K. Ball, Ian M. Franklin	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact